203 related articles for article (PubMed ID: 36232473)
1. Urine NMR Metabolomics for Precision Oncology in Colorectal Cancer.
Brezmes J; Llambrich M; Cumeras R; Gumà J
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232473
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Volatilome and Metabolome Signatures of Colorectal Cancer in Urine: A Systematic Review and Meta-Analysis.
Mallafré-Muro C; Llambrich M; Cumeras R; Pardo A; Brezmes J; Marco S; Gumà J
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064065
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by
Gu J; Xiao Y; Shu D; Liang X; Hu X; Xie Y; Lin D; Li H
Dis Markers; 2019; 2019():3491852. PubMed ID: 31089393
[TBL] [Abstract][Full Text] [Related]
4. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
[TBL] [Abstract][Full Text] [Related]
5. Global serum metabolomics profiling of colorectal cancer.
Hashim NAA; Ab-Rahim S; Suddin LS; Saman MSA; Mazlan M
Mol Clin Oncol; 2019 Jul; 11(1):3-14. PubMed ID: 31289671
[TBL] [Abstract][Full Text] [Related]
6. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.
Zhang F; Zhang Y; Zhao W; Deng K; Wang Z; Yang C; Ma L; Openkova MS; Hou Y; Li K
Oncotarget; 2017 May; 8(21):35460-35472. PubMed ID: 28389626
[TBL] [Abstract][Full Text] [Related]
10. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiling analysis for clinical urine of colorectal cancer.
Ning W; Qiao N; Zhang X; Pei D; Wang W
Asia Pac J Clin Oncol; 2021 Aug; 17(4):403-413. PubMed ID: 34164923
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics and detection of colorectal cancer in humans: a systematic review.
Wang H; Tso VK; Slupsky CM; Fedorak RN
Future Oncol; 2010 Sep; 6(9):1395-406. PubMed ID: 20919825
[TBL] [Abstract][Full Text] [Related]
13. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics analyses of cancer tissue from patients with colorectal cancer.
Kang C; Zhang J; Xue M; Li X; Ding D; Wang Y; Jiang S; Chu FF; Gao Q; Zhang M
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772396
[TBL] [Abstract][Full Text] [Related]
15. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
16. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics in Diabetic Retinopathy: A Systematic Review.
Hou XW; Wang Y; Pan CW
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):4. PubMed ID: 34347011
[TBL] [Abstract][Full Text] [Related]
18. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics of head and neck cancer in biofluids: an integrative systematic review.
Chuchueva N; Carta F; Nguyen HN; Luevano J; Lewis IA; Rios-Castillo I; Fanos V; King E; Swistushkin V; Reshetov I; Rusetsky Y; Shestakova K; Moskaleva N; Mariani C; Castillo-Carniglia A; Grapov D; Fahrmann J; La Frano MR; Puxeddu R; Appolonova SA; Brito A
Metabolomics; 2023 Aug; 19(9):77. PubMed ID: 37644353
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
